Stage IIIC Uveal Melanoma AJCC v7 Completed Phase 2 Trials for Relatlimab (DB14851)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106952 (Stage IIIC Uveal Melanoma AJCC v7) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02519322 | Neoadjuvant and Adjuvant Checkpoint Blockade | Treatment |